Finance

Lists
Why is DSGN down ၁၀.၃၆%?
Dive Deeper
DSGN:NASDAQ
Design Therapeutics Inc
၉.၇၈ US$
-၁၀.၃၆%
(-၁.၁၃) 1D
၉.၇၈ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၁၃, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DSGN...
Open
၁၀.၈၄ US$
High
၁၀.၉၈ US$
Low
၉.၄၈ US$
Mkt. cap
၆၁.၂၀ ကုဋေ
Avg. vol.
၆.၉၀ သိန်း
Volume
၇.၂၇ သိန်း
52-wk high
၁၇.၂၅ US$
52-wk low
၅.၂၈ US$
EPS
-၁.၁၈ US$
Beta
၁.၆၈
Shares outstanding
၆.၂၆ ကုဋေ
No. of employees
၅၅
Open
၁၀.၈၄ US$
High
၁၀.၉၈ US$
Low
၉.၄၈ US$
Mkt. cap
၆၁.၂၀ ကုဋေ
Avg. vol.
၆.၉၀ သိန်း
Volume
၇.၂၇ သိန်း
52-wk high
၁၇.၂၅ US$
52-wk low
၅.၂၈ US$
EPS
-၁.၁၈ US$
Beta
၁.၆၈
Shares outstanding
၆.၂၆ ကုဋေ
No. of employees
၅၅
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၇ နာရီ
Companies Like Design Therapeutics (NASDAQ:DSGN) Are In A Position To Invest In Growth
About Design Therapeutics Inc
CEO-
Employees၅၅
Founded၂၀၁၇
Headquartersကားလ်စ်ဘတ်, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 5 analysts giving stock ratings to DSGN in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for DSGN in the last 3 months.
Highest
Current ၉.၇၈ US$
၄၀.၅၄ US$ (+၃၁၄.၅၂%)
Average
၂၆.၁၁ US$ (+၁၆၆.၉၇%)
Lowest
၂၀.၀၀ US$ (+၁၀၄.၅၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Leerink Partners
Buy
Reiterated
၂၂.၀၀ US$
+၁၂၄.၉%
10/13/2026
Tianqi Hang
Wells Fargo
Buy
Initiated
၂၆.၀၀ US$
+၁၆၅.၈%
10/12/2026
Unknown Analyst
Wells Fargo
Buy
Initiated
၂၆.၀၀ US$
+၁၆၅.၈%
10/02/2026
Unknown Analyst
Cantor Fitzgerald
Buy
Maintained
၄၀.၅၄ US$
+၃၁၄.၅%
08/05/2026
Adam Vogel
Craig-Hallum
Buy
Maintained
၂၂.၀၀ US$
+၁၂၄.၉%
08/04/2026
Leonid Timashev
RBC Capital
Buy
Maintained
၂၀.၀၀ US$
+၁၀၄.၅%
08/03/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
၂၁.၀၀ US$
+၁၁၄.၇%
06/15/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
၂၀.၀၀ US$
+၁၀၄.၅%
05/27/2026
Faisal Khurshid
Jefferies
Buy
Initiated
၁၅.၀၀ US$
+၅၃.၄%
03/15/2026
Luca Issi
RBC Capital
Buy
Reiterated
၁၄.၀၀ US$
+၄၃.၁%
03/09/2026
Last report
၂၀၂၆ ဩ ၃
Fiscal period
Q2 2026
-၀.၃၂ US$ / -၀.၃၄ US$
+၇.၀၆%beat
Revenue / Est. (USD)
- / ၀.၀၀
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
၁.၄၆ ကုဋေ
၁.၃၄ ကုဋေ
၁.၄၄ ကုဋေ
၁.၆၄ ကုဋေ
Cost of revenue
၁.၄၆ ကုဋေ
၁.၃၄ ကုဋေ
၁.၄၄ ကုဋေ
၁.၆၄ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၄.၇၂ သန်း
၄.၇၄ သန်း
၅.၃၃ သန်း
၅.၇၉ သန်း
Operating expense
၄.၇၂ သန်း
၄.၇၄ သန်း
၅.၃၃ သန်း
၅.၇၉ သန်း
Total operating expenses
၁.၉၃ ကုဋေ
၁.၈၂ ကုဋေ
၁.၉၇ ကုဋေ
၂.၂၂ ကုဋေ
Operating income
-၁.၉၃ ကုဋေ
-၁.၈၂ ကုဋေ
-၁.၉၇ ကုဋေ
-၂.၂၂ ကုဋေ
Other non operating income
-
-
-
-
EBT including unusual items
-၁.၇၀ ကုဋေ
-၁.၆၀ ကုဋေ
-၁.၇၆ ကုဋေ
-၂.၀၂ ကုဋေ
EBT excluding unusual items
-၁.၇၀ ကုဋေ
-၁.၆၀ ကုဋေ
-၁.၇၆ ကုဋေ
-၂.၀၂ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၁.၇၀ ကုဋေ
-၁.၆၀ ကုဋေ
-၁.၇၆ ကုဋေ
-၂.၀၂ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၃၀
-၀.၂၇
-၀.၂၉
-၀.၃၂
Interest and investment income
၂.၃၁ သန်း
၂.၁၇ သန်း
၂.၀၇ သန်း
၂.၀၁ သန်း
Interest expense
-
-
-
-
Net interest expenses
၂.၃၁ သန်း
၂.၁၇ သန်း
၂.၀၇ သန်း
၂.၀၁ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၉၂ ကုဋေ
-၁.၈၀ ကုဋေ
-၁.၉၅ ကုဋေ
-၂.၂၀ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ